Rosehip oil for stretch marks: the trials, the blends and the caveats

If you scan the clinical literature for rosehip oil and stretch marks you quickly land on a single, reasonably well-designed pregnancy trial. The study tested a commercial anti‑stretch‑mark cream that contained hydroxyprolisilane‑C, rosehip oil, Centella asiatica triterpenes and vitamin E, and compared it with a placebo cream in a randomized, double‑blind design. The investigators reported that the product reduced progression of existing striae and, in women without prior stretch marks, produced far fewer new striae than placebo (incidence 5.6% versus 35%, P = 0.031). They also reported smaller increases in severity among women who developed new marks while using the active cream compared with placebo (difference in severity 0.14 versus 0.47, P = 0.031). The paper’s overall incidence numbers and some subgroup results are a little mixed, but the preventive signal in women without previous striae is the clearest positive outcome from the trial.¹

The pregnancy trial, in plain terms

The trial was randomized, double‑blind and placebo‑controlled, and it explicitly tested a marketed anti‑stretch‑mark cream against a cream base without the active ingredients. Among the comparisons reported, severity of existing marks increased significantly in the placebo group but not in the treated group, and the incidence of new striae in previously unaffected women was much lower with the active cream (5.6% vs 35%, P = 0.031). These are the findings most often cited when people claim clinical evidence for rosehip in pregnancy.¹

It’s worth noting that the paper reports some null or non‑significant overall incidence numbers (overall incidence for control 33.3% and treated 37.6%, non‑significant), so the positive findings are concentrated in particular subgroup comparisons and in severity metrics rather than a simple, across‑the‑board prevention result.¹

Why you can’t credit rosehip oil alone

The product tested in the trial was a multi‑ingredient cream. In that formulation hydroxyprolisilane‑C, Centella asiatica triterpenes and vitamin E sat alongside rosehip oil, so the trial cannot isolate the effect of rosehip oil on stretch marks. Any or all of the actives, or the combination, could explain the outcome.¹

That pattern — testing blends or formulations rather than a single oil — is common in the cosmetic literature. For example, laboratory work on nanocapsules paired rosehip oil with kojic acid dipalmitate to improve stability and epidermal delivery, which speaks to formulation science but not to the oil acting alone. Likewise, a nanoemulsion study combined rosehip oil with other vegetable oils and retinol for acne and scar‑related outcomes; again, the presence of multiple active ingredients prevents attribution to rosehip oil by itself.^2,3

A recent narrative review of Rosa canina highlights its varied bioactive content and broad interest in nutrition and cosmetics, but reviews that summarize many uses can’t substitute for trials that test a single ingredient for a specific skin indication.⁴

Prevention is not the same as fading old marks

The clearest positive signal from the pregnancy trial was prevention of new striae in women who had no previous marks; the same study did not demonstrate that the cream reliably faded established stretch marks. The trial reported that severity increased in the control group but not in the treated group, which suggests arresting progression rather than reversing existing lesions.¹

That distinction matters if your goal is cosmetic improvement of mature striae. Evidence that a topically applied rosehip product can stimulate dermal remodelling or collagen in ways that fade old lines is thin. There is lab and animal work suggesting rosehip formulations can support tissue repair: a rosehip oil emulsion increased fibroblast proliferation in cell assays and accelerated healing of chemically induced oral mucosal ulcers in an animal model, with reduced inflammatory cells and increased collagen at early time points. That supports biological plausibility for effects on connective tissue, but it is an experimental wound‑healing model, not a human trial of established stretch marks.⁵

Formulation and delivery matter. An in vitro study of polymeric nanocapsules showed that a kojic acid derivative associated with rosehip oil can reach the epidermis and exhibit antioxidant and tyrosinase‑inhibiting activity in cell systems. Such delivery work is important for making topical actives get to the right skin layer, but it doesn’t show that rosehip oil by itself will remodel dermal collagen or fade mature striae.²

What rosehip oil contains, and why people think it might help

Cold‑pressed rosehip oil is a complex lipid fraction. Chemical analyses of commercial rosehip oils show a high proportion of polyunsaturated fatty acids, with varying omega‑6/omega‑3 balances depending on the sample, and characteristic FTIR and UV markers used for quality control. Those fatty acids and minor components could plausibly support barrier function and skin flexibility, which is part of the rationale for using oils in pregnancy and stretching skin.⁶

Beyond lipids, Rosa canina contains phenolics, carotenoids, tocopherols and vitamin C in its fruit and seed fractions, which have antioxidant and anti‑inflammatory potential. Reviews and compositional studies describe these bioactives, which contribute to the argument that rosehip preparations might mitigate oxidative or inflammatory pathways that participate in early stria formation — again, this is plausibility rather than direct clinical proof for stretch marks.⁴

There is also mechanistic laboratory work on triterpenoids from Rosa species that modulate cellular lipid handling and nuclear receptor pathways in adipocyte models; those findings are interesting background on how plant components can affect tissue biology, but translating such molecular signals into meaningful effects on dermal architecture and stretch marks in people requires targeted clinical trials.

Practical takeaways and the limits of the evidence

If you’re looking for evidence that rosehip oil will prevent stretch marks in pregnancy, the single randomized trial of a rosehip‑containing cream provides encouraging but limited support: the product reduced new striae in women without prior marks and blunted progression of severity in some comparisons, but the cream had multiple active ingredients, so rosehip’s individual contribution is unknown.¹

If the aim is to fade established striae, the clinical evidence is absent. Experimental studies suggest rosehip formulations can stimulate fibroblasts and collagen in cell and animal models, which keeps the question open, but those data are not a substitute for human trials of mature stretch marks.⁵

Finally, some of the apparent benefit of a commercial cream may come from routine emollient use and massage. Hydration and mechanical manipulation of the skin modify comfort and appearance to some degree; those non‑specific effects are part of why placebo‑controlled trials are important and why single‑ingredient attribution is tricky when blends are tested.

Caveats and research gaps

We need trials that test rosehip oil alone (or carefully dose its key constituents) against appropriate controls, and we need separate trials for prevention and for treatment of existing striae. The current best human evidence is a positive trial of a multi‑ingredient cream in pregnancy; that is a useful finding, but it is not the same as proof that topical rosehip oil by itself prevents or diminishes stretch marks.^1,4

Until such studies exist, the most honest reading is this: rosehip‑containing creams have some clinical data behind them, primarily for prevention in pregnancy, but the evidence stops short of showing that rosehip oil alone or any rosehip product will reliably fade mature stretch marks.¹

For anyone worried about significant or rapidly changing striae, a consultation with a dermatologist is the sensible next step.